Article Text

Download PDFPDF

Highlights from this issue
  1. Nick Brown, Editor in chief1,2,3
  1. 1 Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden
  2. 2 Department of Paediatrics, Länssjukhuset Gävle-Sandviken, Gävle, Sweden
  3. 3 Department of Child Health, Aga Khan University, Karachi, Pakistan
  1. Correspondence to Dr Nick Brown, Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala University, 752 36 Uppsala, Sweden; nickjwbrown{at}gmail.com

Statistics from Altmetric.com

A ‘better’ alternative?

Like many, you may have been unwittingly seduced by the relaxed public health stance to vaping, the case being built (or afforded protection from scrutiny) on the basis of the lack of tar and carbon monoxide. Let’s look at this from another angle, though. E cigarettes are addictive and include components with properties that, were they marketed as a new drug would never be licensed: pro-inflammatory and proteomic effects on the airway; increased bacterial adherence; hypersensitivity, the list goes on. In combination these are as destructive as ‘old fashioned’ tobacco in terms of production of emphysema in a murine model.

From the perspective of protecting the health of young people, these data alone raise red flags and collectively show clear breeches of the European Tobacco Products Directive which prohibits the addition of compounds which pose a risk to human health, either when heated …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles